StockData
TransMedics Group, Inc. logo

TransMedics Group, Inc. (TMDX) stock

TMDXNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 14/3030% below fair value
$93.91+1.70 (+1.84%)

Close on Nov 17, 2026Market cap $3.26BP/E 24.4Yield 0.00%

TransMedics total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

TransMedics's total debt was $20.00M at Jun 30, 2026. For fiscal 2025 it was $10.00M, down 83.0% from the year before. The highest annual figure on record is $58.70M in fiscal 2022.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$10.00M-83.0%
FY2022Dec 31, 2022$58.70M+66.8%
FY2021Dec 31, 2021$35.20M+1.6%
FY2020Dec 31, 2020$34.66M+1.5%
FY2019Dec 28, 2019$34.15M+1.4%
FY2018Dec 29, 2018$33.67M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$20.00M-66.0%
Q1 FY2026Mar 31, 2026$15.00M-74.4%
Q4 FY2025Dec 31, 2025$10.00M-82.9%
Q3 FY2025Sep 30, 2025$5.00M-85.9%
Q1 FY2023Mar 31, 2023$58.80M+66.4%
Q4 FY2022Dec 31, 2022$58.70M+66.8%
Q3 FY2022Sep 30, 2022$58.54M+67.0%
Q2 FY2022Jun 30, 2022$35.48M+1.6%
Q1 FY2022Mar 31, 2022$35.33M+1.6%
Q4 FY2021Dec 31, 2021$35.20M+1.6%
Q3 FY2021Sep 30, 2021$35.06M+1.5%
Q2 FY2021Jun 30, 2021$34.92M+1.5%
Q1 FY2021Mar 31, 2021$34.79M+1.5%
Q4 FY2020Dec 31, 2020$34.66M+1.5%
Q3 FY2020Sep 30, 2020$34.53M+1.5%
Q2 FY2020Jun 30, 2020$34.40M+1.5%
Q1 FY2020Mar 31, 2020$34.27M+1.4%
Q4 FY2019Dec 28, 2019$34.15M+1.4%
Q3 FY2019Sep 28, 2019$34.02M–
Q2 FY2019Jun 29, 2019$33.90M–
Q1 FY2019Mar 30, 2019$33.79M–
Q4 FY2018Dec 29, 2018$33.67M–

More TransMedics figures

See a number that looks wrong?